LBRX · Company research
LB Pharmaceuticals Inc (LBRX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
22records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| LB Pharmaceuticals (NASDAQ:LBRX) Shares Gap Up - What's Next? - MarketBeat | LB Pharmaceuticals (NASDAQ:LBRX) Shares Gap Up - What's Next? MarketBeat | View source ↗ | MarketBeat | Oct 16, 2026 | neutral | 0 | 0.6 |
| LBRX Jan 2027 35.000 call (LBRX270115C00035000) Stock Price, News, Quote & History - Yahoo! Finance Canada | LBRX Jan 2027 35.000 call (LBRX270115C00035000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals (NASDAQ:LBRX) Stock Jumps 8.8% - Should You Buy? - MarketBeat | LB Pharmaceuticals (NASDAQ:LBRX) Stock Jumps 8.8% - Should You Buy? MarketBeat | View source ↗ | MarketBeat | Oct 15, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals (NASDAQ:LBRX) Stock Bumped Down to "Strong Sell" by Zacks Research - MarketBeat | LB Pharmaceuticals (NASDAQ:LBRX) Stock Bumped Down to "Strong Sell" by Zacks Research MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| The medical chief at LB Pharmaceuticals (LBRX) receives 200,000 options exercisable at $37.22. - Stock Titan | The medical chief at LB Pharmaceuticals (LBRX) receives 200,000 options exercisable at $37.22. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| A 200,000-share option award for LB Pharmaceuticals (LBRX) CFO carries a $37.22 exercise price. - Stock Titan | A 200,000-share option award for LB Pharmaceuticals (LBRX) CFO carries a $37.22 exercise price. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 7% - Here's What Happened - MarketBeat | LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 7% - Here's What Happened MarketBeat | View source ↗ | MarketBeat | Oct 12, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals (LBRX) Stock Fair Value Rises As LB 102 Outlook Shifts - Yahoo Finance | LB Pharmaceuticals (LBRX) Stock Fair Value Rises As LB 102 Outlook Shifts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 11, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4) | LB Pharmaceuticals Inc announced equity awards to newly appointed Chief Medical Officer Dr. Susan G. Kozauer and Chief Financial Officer Joseph Miller. Each executive received options to purchase 200,000 shares at an exercise price of $37.22, vesting over 4 years with a 10-year term. The grants were made as inducement awards under Nasdaq Listing Rule 5635(c)(4). | View source ↗ | GlobeNewswire Inc. | Oct 9, 2026 | bullish | 1 | 1 |
| LB Pharmaceuticals (NasdaqGM:LBRX) Stock Price - Simply Wall Street | LB Pharmaceuticals (NasdaqGM:LBRX) Stock Price Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| Can LB Pharmaceuticals (NASDAQ:LBRX) Keep Its Fresh Rebound Going Strong? - Kalkine Media | Can LB Pharmaceuticals (NASDAQ:LBRX) Keep Its Fresh Rebound Going Strong? Kalkine Media | View source ↗ | Kalkine Media | Oct 7, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals (NASDAQ:LBRX) Shares Climb 4.7% - Should You Buy? - MarketBeat | LB Pharmaceuticals (NASDAQ:LBRX) Shares Climb 4.7% - Should You Buy? MarketBeat | View source ↗ | MarketBeat | Oct 7, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals (NASDAQ:LBRX) Stock Rated Buy in New Coverage at Guggenheim - MarketBeat | LB Pharmaceuticals (NASDAQ:LBRX) Stock Rated Buy in New Coverage at Guggenheim MarketBeat | View source ↗ | MarketBeat | Oct 7, 2026 | neutral | 0 | 0.6 |
| A research event will examine LB Pharmaceuticals’ schizophrenia drug before results are expected in the first half of 2027. - Stock Titan | A research event will examine LB Pharmaceuticals’ schizophrenia drug before results are expected in the first half of 2027. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals Inc (LBRX) Stock Price & News - Syfe | LB Pharmaceuticals Inc (LBRX) Stock Price & News Syfe | View source ↗ | Syfe | Sep 26, 2026 | neutral | 0 | 0.6 |
| LBRX: LB Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | LBRX: LB Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Sep 21, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals (Nasdaq:LBRX) - Stock Analysis - Simply Wall Street | LB Pharmaceuticals (Nasdaq:LBRX) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Sep 21, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals Plans $150M Raise for LB-102 Expansion - Stock Titan | LB Pharmaceuticals Plans $150M Raise for LB-102 Expansion Stock Titan | View source ↗ | Stock Titan | Jul 29, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals Prices ~$150 Million Private Placement of Stock and Pre-Funded Warrants - TradingView | LB Pharmaceuticals Prices ~$150 Million Private Placement of Stock and Pre-Funded Warrants TradingView | View source ↗ | TradingView | Jul 29, 2026 | neutral | 0 | 0.6 |
| Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRX - RTTNews | Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRX RTTNews | View source ↗ | RTTNews | Jul 29, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 Potential - Yahoo Finance | LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 Potential Yahoo Finance | View source ↗ | Yahoo Finance | Jul 2, 2026 | neutral | 0 | 0.6 |
| LB Pharmaceuticals: LBRX Stock Price Quote & News - Robinhood | LB Pharmaceuticals: LBRX Stock Price Quote & News Robinhood | View source ↗ | Robinhood | Nov 9, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.